title: Visual trails: do the doors of perception open periodically?
authors.affiliation: Université de Toulouse, Centre de Recherche Cerveau et Cognition, Université Paul Sabatier, Toulouse, France. jcrdubois@gmail.com
authors.forename: Julien
authors.initials: J
authors.lastname: Dubois
authors.forename: Rufin
authors.initials: R
authors.lastname: Vanrullen
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects; D005260:Female; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives; D006213:Hallucinogens / Q000009:adverse effects; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects*; D008297:Male; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives; D008875:Middle Aged; D000078785:Mirtazapine; D010468:Perceptual Disorders / Q000139:chemically induced*; D010879:Piperazines; D000077236:Topiramate; D014196:Trazodone / Q000009:adverse effects; D014230:Triazoles / Q000009:adverse effects; D014796:Visual Perception
chemical_list: D000927:Anticonvulsants; D000928:Antidepressive Agents; D006213:Hallucinogens; D010879:Piperazines; D014230:Triazoles; D000077236:Topiramate; D008803:Mianserin; D005632:Fructose; C051752:nefazodone; D008238:Lysergic Acid Diethylamide; D000078785:Mirtazapine; D014196:Trazodone